Adam Stone joined Perceptive Advisors, a hedge fund focused on supporting the progress of the life sciences industry, in 2006. Previously, he served as Senior Analyst at Ursus Capital. Adam earned his BA degree in molecular biology from Princeton University. Over the last decade, Mr. Stone has helped to grow Perceptive into a multi-billion dollar asset management firm, and internally led the formation of the Perceptive Credit Opportunities Fund. He has played an integral role in the development of several early stage biotech and healthcare companies, currently serving on the boards of Solid Biosciences and Renovia.